NJEDA to Host Life Sciences Panel on Alternative Funding Opportunities at New Jersey Bioscience Center

TRENTON, N.J. (October 2, 2024) – The New Jersey Economic Development Authority (NJEDA) will host a panel discussion focused on alternative funding opportunities to help advance New Jersey-based life sciences companies. Attendees will hear from industry leaders on how to secure funding from non-traditional sources, how the next generation of drugs, diagnostics, and devices will be funded, and ways to fund early and emerging commercial biomedical research.

WHEN:           Thursday, October 24, 2024
5:00 p.m. – 7:00 p.m.

WHO:              Josh Barer, Managing Director at Hibiscus BioVentures
Kathleen Coviello, Chief Economic Transformation Officer, NJEDA
Rik Mehta, Cofounder and CEO of Lactiga US, Inc
John Pennett, Partner, Life Sciences and Technology Group, Eisner Advisory Group LLC
Jorge Ramirez, Vice President, M&A and Business Development, Quest Diagnostics.
Judith Sheft, Executive Director, New Jersey Commission on Science, Innovation and Technology

WHERE:         New Jersey Bioscience Center
675 U.S. Highway 1
North Brunswick, N.J.

PRESS:            OPEN; press wishing to attend should RSVP to media@njeda.gov.

Members of the public can register to attend here.

To learn more about NJEDA resources for businesses, call NJEDA Customer Care at 844-965-1125 or visit https://www.njeda.gov and follow @NewJerseyEDA on Facebook, Twitter, Instagram, and LinkedIn.

###